$CBUS
Cibus, Inc.

2018 Q1 Form 10-K Financial Statement

#000119312518080923 Filed on March 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 2016 Q4
Revenue $11.00K $508.0K $70.00K
YoY Change -80.0% 27.32%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Gross Profit $11.00K $508.0K $70.00K
YoY Change -80.0% 155.28%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $2.676M $14.74M $2.920M
YoY Change 69.58% 121.0%
% of Gross Profit 24327.27% 2901.77% 4171.43%
Research & Development $1.048M $11.51M $1.730M
YoY Change -17.22% 104.11%
% of Gross Profit 9527.27% 2265.35% 2471.43%
Depreciation & Amortization $156.0K $551.0K $280.0K
YoY Change 17.29% 59.71%
% of Gross Profit 1418.18% 108.46% 400.0%
Operating Expenses $4.307M $26.30M $4.640M
YoY Change 51.44% 113.66%
Operating Profit -$4.296M -$25.79M -$4.570M
YoY Change 54.03% 112.97%
Interest Expense $235.0K $261.0K $20.00K
YoY Change -1778.57% 5120.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.370M -$25.98M -$4.550M
YoY Change 54.31% 114.96%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.370M -$25.98M -$4.550M
YoY Change 54.31% 114.96%
Net Earnings / Revenue -39727.27% -5114.17% -6500.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$156.9K -$1.122M -$103.8K
COMMON SHARES
Basic Shares Outstanding 28.06M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.70M $56.70M $5.000M
YoY Change 1590.0% 1034.0%
Cash & Equivalents $50.70M $56.70M $5.026M
Short-Term Investments
Other Short-Term Assets $2.100M $600.0K $300.0K
YoY Change 250.0% 100.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $110.0K
Other Receivables $0.00 $200.0K $100.0K
Total Short-Term Assets $52.83M $57.50M $5.465M
YoY Change 1327.84% 945.45%
LONG-TERM ASSETS
Property, Plant & Equipment $18.77M $14.40M $10.99M
YoY Change 67.56% 30.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $270.0K $400.0K $164.0K
YoY Change 35.0% 100.0%
Total Long-Term Assets $19.04M $14.70M $11.16M
YoY Change 66.99% 32.43%
TOTAL ASSETS
Total Short-Term Assets $52.83M $57.50M $5.465M
Total Long-Term Assets $19.04M $14.70M $11.16M
Total Assets $71.87M $72.20M $16.62M
YoY Change 375.94% 334.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $441.0K $1.000M $357.0K
YoY Change -37.0% 150.0%
Accrued Expenses $1.256M $1.800M $363.0K
YoY Change 25.6% 157.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.972M $4.300M $2.865M
YoY Change -25.7% 48.28%
LONG-TERM LIABILITIES
Long-Term Debt $14.80M $10.10M $0.00
YoY Change
Other Long-Term Liabilities $300.0K $300.0K $600.0K
YoY Change -50.0% -50.0%
Total Long-Term Liabilities $15.10M $10.40M $600.0K
YoY Change 2416.67% 1633.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.972M $4.300M $2.865M
Total Long-Term Liabilities $15.10M $10.40M $600.0K
Total Liabilities $18.01M $14.70M $3.504M
YoY Change 283.13% 320.0%
SHAREHOLDERS EQUITY
Retained Earnings -$58.92M -$28.57M
YoY Change
Common Stock $112.8M $41.69M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $53.86M $57.50M $13.12M
YoY Change
Total Liabilities & Shareholders Equity $71.87M $72.20M $16.62M
YoY Change 375.94% 334.94%

Cashflow Statement

Concept 2018 Q1 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$4.370M -$25.98M -$4.550M
YoY Change 54.31% 114.96%
Depreciation, Depletion And Amortization $156.0K $551.0K $280.0K
YoY Change 17.29% 59.71%
Cash From Operating Activities -$6.565M -$12.79M -$7.040M
YoY Change 283.92% 38.41%
INVESTING ACTIVITIES
Capital Expenditures $41.00K $779.0K -$220.0K
YoY Change -86.86% -92.53%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$41.00K -$779.0K -$220.0K
YoY Change -86.77% -92.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $61.29M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 645.0K 65.20M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -6.565M -12.79M -7.040M
Cash From Investing Activities -41.00K -779.0K -220.0K
Cash From Financing Activities 645.0K 65.20M 0.000
Net Change In Cash -5.961M 51.64M -7.260M
YoY Change 195.1% -362.64%
FREE CASH FLOW
Cash From Operating Activities -$6.565M -$12.79M -$7.040M
Capital Expenditures $41.00K $779.0K -$220.0K
Free Cash Flow -$6.606M -$13.56M -$6.820M
YoY Change 226.71% -31.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28062315 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2017Q3 clxt Shares Authorized
SharesAuthorized
325000000 shares
CY2017Q3 clxt Number Of Lease Extension Options
NumberOfLeaseExtensionOptions
4 Options
CY2017Q3 dei Entity Public Float
EntityPublicFloat
135919500
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
303000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-10436000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24687000
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14900000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
24257000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
363000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
5465000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
110000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
732000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41685000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
357000
CY2016Q4 us-gaap Assets
Assets
16623000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5026000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19600000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19600000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
44000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
101000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10221000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8974000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
592000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
81000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
574000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10177000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
53000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
639000
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1712000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
332000
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
47000
CY2016Q4 us-gaap Liabilities
Liabilities
3504000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16623000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2865000
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24700000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
164000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
282000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10994000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11726000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28568000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1930600 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.45
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
13119000
CY2016Q4 clxt Deferred Tax Assets Liabilities Deferred Income
DeferredTaxAssetsLiabilitiesDeferredIncome
9000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
893000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
57457000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1283000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
112021000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1023000
CY2017Q4 us-gaap Assets
Assets
72167000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56664000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27718780 shares
CY2017Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
1337000
CY2017Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1337000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27718780 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2017Q4 us-gaap Contractual Obligation
ContractualObligation
30122000
CY2017Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1337000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2601000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9252000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
735000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
8000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
576000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15393000
CY2017Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
1337000
CY2017Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1130000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12792000
CY2017Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
23644000
CY2017Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1336000
CY2017Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1054000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2600000
CY2017Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1336000
CY2017Q4 us-gaap Liabilities
Liabilities
14691000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72167000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4254000
CY2017Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
300000000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
289000
CY2017Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
30042000
CY2017Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
1336000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2691000
CY2017Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1350000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
945000
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
167000
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5000000
CY2017Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
23644000
CY2017Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1336000
CY2017Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10148000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
80000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
41600000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
357000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
76000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
626000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14353000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15636000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54548000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
20949000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
49965000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1244968 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.20
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3883432 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.16
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
57476000
CY2017Q4 clxt Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
2131000
CY2017Q4 clxt Deferred Tax Assets Liabilities Deferred Income
DeferredTaxAssetsLiabilitiesDeferredIncome
-1000
CY2017Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
100 pure
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3300000
CY2017Q3 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
3100000
CY2017Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
58000000
CY2017Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2.45 pure
CY2017Q3 us-gaap Lessee Finance Lease Renewal Term
LesseeFinanceLeaseRenewalTerm
P5Y
CY2017Q3 us-gaap Lessee Finance Lease Term Of Contract
LesseeFinanceLeaseTermOfContract
P20Y
CY2017Q3 us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
7000000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
692000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
24384000
CY2015 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
751000
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
7086000
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
47000
CY2015 us-gaap Depreciation
Depreciation
147000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88
CY2015 us-gaap Dividends
Dividends
110000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2015 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
186000
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5889000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2002000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-565000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
93000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1765000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
237000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-28000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-59000
CY2015 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-261000
CY2015 us-gaap Interest Paid
InterestPaid
261000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-665000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6691000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
31740000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-5889000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-5814000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
272000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6725740 shares
CY2015 clxt Stock Issued During Period Value Capital Contribution
StockIssuedDuringPeriodValueCapitalContribution
40000000
CY2015 us-gaap Payments Of Dividends
PaymentsOfDividends
110000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
665000
CY2015 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
2050000
CY2015 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
30000000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2766000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
1272000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
692000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M10D
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3569000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.543 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0165 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.02
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2015 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-1265000
CY2015 clxt Repayment Of Advances From Parent
RepaymentOfAdvancesFromParent
200000
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12092000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
51638000
CY2017 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
The Company provides a 401(k) defined contribution plan (the Plan) for participation by all regular fulltime employees who have completed three months of service
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Entity Registrant Name
EntityRegistrantName
CALYXT, INC.
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001705843
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
26297000
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
93000
CY2017 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03 pure
CY2017 us-gaap Depreciation
Depreciation
551000
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1.00 pure
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y2M12D
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Type
DocumentType
10-K
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2017 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
200000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-190000
CY2017 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25980000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8833000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-408000
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
613000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5638000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-154000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-110000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
591000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
3346000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
665000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
537000
CY2017 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1000
CY2017 us-gaap Interest Paid
InterestPaid
200000
CY2017 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
1600000
CY2017 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>1. Nature of Business</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Calyxt, Inc., formerly known as Cellectis Plant Sciences, Inc. (the Company or Calyxt), was founded in 2010 and incorporated in Delaware. The Company is headquartered in New Brighton, Minnesota. Calyxt is a consumer-centric, food- and agriculture-focused company. The Company changed its name from Cellectis Plant Sciences, Inc. to Calyxt, Inc. on May&#xA0;4, 2015. Prior to the Company&#x2019;s initial public offering (IPO) on July&#xA0;25, 2017, Calyxt was a wholly owned subsidiary of Cellectis S.A. (&#x201C;Cellectis&#x201D; or &#x201C;Parent&#x201D;). As of December&#xA0;31, 2017, Cellectis owned approximately 79.7% of the Company&#x2019;s outstanding common stock. Calyxt&#x2019;s common stock is listed on the Nasdaq market under the ticker symbol &#x201C;CLXT&#x201D;.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b><i>Initial Public Offering</i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> On July&#xA0;25, 2017, the Company completed an IPO of its common stock, in which it sold an aggregate of 8,050,000 shares of its common stock at a price of $8.00 per share, including 1,050,000 shares of common stock pursuant to the exercise of the underwriters&#x2019; option to purchase additional shares. In the aggregate, the Company received net proceeds from the IPO and exercise of the overallotment of approximately $58.0&#xA0;million, after deducting underwriting discounts and commissions of $3.1&#xA0;million and offering expenses totaling approximately $3.3&#xA0;million. As part of the IPO, Cellectis purchased 2,500,000 shares of the Company&#x2019;s common stock for a value of $20.0&#xA0;million, which is included in the net proceeds of approximately $58.0&#xA0;million. The Company used $5.7&#xA0;million of the proceeds from Cellectis to pay a portion of the outstanding obligations owed to Cellectis.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b><i>Stock Splits</i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> On June&#xA0;14, 2017, pursuant to the authorization provided in a written consent in lieu of a special meeting of the Company, the Company effected a stock split of the Company&#x2019;s common stock at a ratio of <font style="white-space:nowrap"><font style="white-space:nowrap">100-for-1</font></font> and increased the number of shares of common stock authorized for issuance to 30,000,000 by filing a Certificate of Amendment with the Secretary of State of the State of Delaware.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> On July&#xA0;25, 2017, the Company amended its Amended and Restated Certificate of Incorporation to increase the authorized capital stock of the Company to 325,000,000 shares of which 275,000,000 shares are designated common stock, par value $0.0001, and 50,000,000 shares are designated preferred stock, par value $0.0001.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> On July&#xA0;25, 2017, concurrently with the closing of the IPO, the Company effected a stock split of the Company&#x2019;s common stock at a ratio of <font style="white-space:nowrap"><font style="white-space:nowrap">2.45-for-1.</font></font> As a result of the stock split, each share of issued and outstanding common stock was converted into 2.45 shares of issued and outstanding common stock without changing the par value per share.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Since the par value of the common stock remained at $0.0001 per share subsequent to each stock split, the value of common stock recorded to the Company&#x2019;s balance sheets has been retroactively increased to reflect the par value of the increased number of outstanding shares, with a corresponding decrease to additional <font style="white-space:nowrap">paid-in</font> capital. All share and per share data for periods occurring prior to the stock split that are included in the financial statements and related notes have been retroactively restated to reflect the stock splits.</p> </div>
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-779000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12785000
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
65202000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-25980000
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-25789000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
270000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
779000
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3312000
CY2017 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
3000000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
61292000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
265000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11556000
CY2017 us-gaap Sale Leaseback Transaction Date
SaleLeasebackTransactionDate
2017-09-06
CY2017 us-gaap Sale Leaseback Transaction Annual Rental Payments
SaleLeasebackTransactionAnnualRentalPayments
1400000
CY2017 us-gaap Sale Leaseback Transaction Imputed Interest Rate
SaleLeasebackTransactionImputedInterestRate
0.08 pure
CY2017 us-gaap Sales Revenue Net
SalesRevenueNet
508000
CY2017 us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
6957000
CY2017 us-gaap Sale Leaseback Transaction Rent Expense
SaleLeasebackTransactionRentExpense
490000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
12092000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.451 pure
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.95
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14741000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.274 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0125 pure
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
98735 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.42
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.23
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.29
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6700000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0239 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1300000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2120347 shares
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
68780 shares
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57980000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
265000
CY2017 dei Trading Symbol
TradingSymbol
CLXT
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23153661 shares
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to stock-based compensation and the valuation allowance for deferred tax assets and derivatives. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p> </div>
CY2017 clxt Net Operating Loss Carryforwards Expiration Beginning Year
NetOperatingLossCarryforwardsExpirationBeginningYear
2032
CY2017 clxt Operating Leases Expiration Date
OperatingLeasesExpirationDate
2018-05
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-12109000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
271000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10424000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5638000
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
399000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
948000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
12508000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
66000
CY2016 us-gaap Depreciation
Depreciation
345000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2016 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
28000
CY2017 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-482000
CY2017 clxt Defined Contribution Plan Additional Matching Contribution Percent Of Match
DefinedContributionPlanAdditionalMatchingContributionPercentOfMatch
0.50 pure
CY2017 clxt Repayment Of Advances From Parent
RepaymentOfAdvancesFromParent
3000000
CY2017 clxt Property And Equipment Included In Financing Lease Obligation
PropertyAndEquipmentIncludedInFinancingLeaseObligation
3130000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
948000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-19661000
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200000
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12086000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4109000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
58000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
418000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-144000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
88000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4260000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
325000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-107000
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
137000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
53000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
387000
CY2016 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5000
CY2016 us-gaap Interest Paid
InterestPaid
5000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10424000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9237000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-12086000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6670000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.300 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0064 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.03
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19600000 shares
CY2016 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
1702000

Files In Submission

Name View Source Status
0001193125-18-080923-index-headers.html Edgar Link pending
0001193125-18-080923-index.html Edgar Link pending
0001193125-18-080923.txt Edgar Link pending
0001193125-18-080923-xbrl.zip Edgar Link pending
clxt-20171231.xml Edgar Link completed
clxt-20171231.xsd Edgar Link pending
clxt-20171231_cal.xml Edgar Link unprocessable
clxt-20171231_def.xml Edgar Link unprocessable
clxt-20171231_lab.xml Edgar Link unprocessable
clxt-20171231_pre.xml Edgar Link unprocessable
d519892d10k.htm Edgar Link pending
d519892dex1014.htm Edgar Link pending
d519892dex102.htm Edgar Link pending
d519892dex1024.htm Edgar Link pending
d519892dex103.htm Edgar Link pending
d519892dex104.htm Edgar Link pending
d519892dex105.htm Edgar Link pending
d519892dex231.htm Edgar Link pending
d519892dex31.htm Edgar Link pending
d519892dex311.htm Edgar Link pending
d519892dex312.htm Edgar Link pending
d519892dex32.htm Edgar Link pending
d519892dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g519892g02r78.jpg Edgar Link pending
g519892g10i61.jpg Edgar Link pending
g519892g15k44.jpg Edgar Link pending
g519892g28p96.jpg Edgar Link pending
g519892g47c07.jpg Edgar Link pending
g519892g62g95.jpg Edgar Link pending
g519892g72n12.jpg Edgar Link pending
g519892g73f33.jpg Edgar Link pending
g519892g85e67.jpg Edgar Link pending
g519892g90l91.jpg Edgar Link pending
g519892logoosm.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending